BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This relation is crucial for reproducing the observed CML progression, as an increase in the BCR::ABL1 mutation strength (accelerating progression) compensates for a decrease in the division rate of HSCs (which, in contrast, slows down progression).